Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.

Parkinson's disease (PD) patients who present with tremor and maintain a predominance of tremor have a better prognosis. Similarly, PD patients with high levels of uric acid (UA), a natural neuroprotectant, have also a better disease course. Our aim was to investigate whether PD motor subtypes...

Full description

Bibliographic Details
Main Authors: Ismael Huertas, Silvia Jesús, José Antonio Lojo, Francisco Javier García-Gómez, María Teresa Cáceres-Redondo, Juan Manuel Oropesa-Ruiz, Fátima Carrillo, Laura Vargas-Gonzalez, Juan Francisco Martín Rodríguez, Pilar Gómez-Garre, David García-Solís, Pablo Mir
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5373593?pdf=render
_version_ 1818325042066358272
author Ismael Huertas
Silvia Jesús
José Antonio Lojo
Francisco Javier García-Gómez
María Teresa Cáceres-Redondo
Juan Manuel Oropesa-Ruiz
Fátima Carrillo
Laura Vargas-Gonzalez
Juan Francisco Martín Rodríguez
Pilar Gómez-Garre
David García-Solís
Pablo Mir
author_facet Ismael Huertas
Silvia Jesús
José Antonio Lojo
Francisco Javier García-Gómez
María Teresa Cáceres-Redondo
Juan Manuel Oropesa-Ruiz
Fátima Carrillo
Laura Vargas-Gonzalez
Juan Francisco Martín Rodríguez
Pilar Gómez-Garre
David García-Solís
Pablo Mir
author_sort Ismael Huertas
collection DOAJ
description Parkinson's disease (PD) patients who present with tremor and maintain a predominance of tremor have a better prognosis. Similarly, PD patients with high levels of uric acid (UA), a natural neuroprotectant, have also a better disease course. Our aim was to investigate whether PD motor subtypes differ in their levels of UA, and if these differences correlate with the degree of dopamine transporter (DAT) availability. We included 75 PD patients from whom we collected information about their motor symptoms, DAT imaging and UA concentration levels. Based on the predominance of their motor symptoms, patients were classified into postural instability and gait disorder (PIGD, n = 36), intermediate (I, n = 22), and tremor-dominant (TD, n = 17) subtypes. The levels of UA and striatal DAT were compared across subtypes and the correlation between these two measures was also explored. We found that PIGD patients had lower levels of UA (3.7 vs 4.5 vs 5.3 mg/dL; P<0.001) and striatal DAT than patients with an intermediate or TD phenotype. Furthermore, UA levels significantly correlated with the levels of striatal DAT. We also observed that some PIGD (25%) and I (45%) patients had a predominance of tremor at disease onset. We speculate that UA might be involved in the maintenance of the less damaging TD phenotype and thus also in the conversion from TD to PIGD. Low levels of this natural antioxidant could lead to a major neuronal damage and therefore influence the conversion to a more severe motor phenotype.
first_indexed 2024-12-13T11:38:11Z
format Article
id doaj.art-61d73dd05dd44f138ac5cd6393e23ddb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T11:38:11Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-61d73dd05dd44f138ac5cd6393e23ddb2022-12-21T23:47:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017464410.1371/journal.pone.0174644Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.Ismael HuertasSilvia JesúsJosé Antonio LojoFrancisco Javier García-GómezMaría Teresa Cáceres-RedondoJuan Manuel Oropesa-RuizFátima CarrilloLaura Vargas-GonzalezJuan Francisco Martín RodríguezPilar Gómez-GarreDavid García-SolísPablo MirParkinson's disease (PD) patients who present with tremor and maintain a predominance of tremor have a better prognosis. Similarly, PD patients with high levels of uric acid (UA), a natural neuroprotectant, have also a better disease course. Our aim was to investigate whether PD motor subtypes differ in their levels of UA, and if these differences correlate with the degree of dopamine transporter (DAT) availability. We included 75 PD patients from whom we collected information about their motor symptoms, DAT imaging and UA concentration levels. Based on the predominance of their motor symptoms, patients were classified into postural instability and gait disorder (PIGD, n = 36), intermediate (I, n = 22), and tremor-dominant (TD, n = 17) subtypes. The levels of UA and striatal DAT were compared across subtypes and the correlation between these two measures was also explored. We found that PIGD patients had lower levels of UA (3.7 vs 4.5 vs 5.3 mg/dL; P<0.001) and striatal DAT than patients with an intermediate or TD phenotype. Furthermore, UA levels significantly correlated with the levels of striatal DAT. We also observed that some PIGD (25%) and I (45%) patients had a predominance of tremor at disease onset. We speculate that UA might be involved in the maintenance of the less damaging TD phenotype and thus also in the conversion from TD to PIGD. Low levels of this natural antioxidant could lead to a major neuronal damage and therefore influence the conversion to a more severe motor phenotype.http://europepmc.org/articles/PMC5373593?pdf=render
spellingShingle Ismael Huertas
Silvia Jesús
José Antonio Lojo
Francisco Javier García-Gómez
María Teresa Cáceres-Redondo
Juan Manuel Oropesa-Ruiz
Fátima Carrillo
Laura Vargas-Gonzalez
Juan Francisco Martín Rodríguez
Pilar Gómez-Garre
David García-Solís
Pablo Mir
Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
PLoS ONE
title Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
title_full Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
title_fullStr Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
title_full_unstemmed Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
title_short Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype.
title_sort lower levels of uric acid and striatal dopamine in non tremor dominant parkinson s disease subtype
url http://europepmc.org/articles/PMC5373593?pdf=render
work_keys_str_mv AT ismaelhuertas lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT silviajesus lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT joseantoniolojo lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT franciscojaviergarciagomez lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT mariateresacaceresredondo lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT juanmanueloropesaruiz lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT fatimacarrillo lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT lauravargasgonzalez lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT juanfranciscomartinrodriguez lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT pilargomezgarre lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT davidgarciasolis lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype
AT pablomir lowerlevelsofuricacidandstriataldopamineinnontremordominantparkinsonsdiseasesubtype